Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Perry

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Neuro-Oncology Advances|November 12, 2021
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2021
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO GuidelineNimish A Mohile, Hans Messersmith, Na Tosha Gatson, et al.
Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.
Frontiers in Oncology|December 15, 2022
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first reportChia-Lin Tseng, Hanbo Chen, James Stewart, et al.
Technology in Cancer Research & Treatment|June 28, 2022
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort AnalysisJames Stewart, Arjun Sahgal, Aimee K M Chan, et al.
The Lancet. Oncology|May 14, 2026
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trialJay S Detsky, Adrian Wai Chan, Daniel Moore-Palhares, et al.
Data in Brief|April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Journal of Virology|April 13, 2018
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea PigsChristine A Bricault, James M Kovacs, Alexander Badamchi-Zadeh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Neuro-Oncology Advances|November 12, 2021
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2021
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO GuidelineNimish A Mohile, Hans Messersmith, Na Tosha Gatson, et al.
Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.
Frontiers in Oncology|December 15, 2022
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first reportChia-Lin Tseng, Hanbo Chen, James Stewart, et al.
Technology in Cancer Research & Treatment|June 28, 2022
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort AnalysisJames Stewart, Arjun Sahgal, Aimee K M Chan, et al.
The Lancet. Oncology|May 14, 2026
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trialJay S Detsky, Adrian Wai Chan, Daniel Moore-Palhares, et al.
Data in Brief|April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Journal of Virology|April 13, 2018
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea PigsChristine A Bricault, James M Kovacs, Alexander Badamchi-Zadeh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastomaPejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Pageof 11